25556 Federal Register / Vol. 74, No. 101 / Thursday, May 28, 2009 / Notices 

Dated: May 20, 2009. 

Jeffrey Shuren, 

Associate Commissioner for Policy and 

Planning. 

[FR Doc. E9–12317 Filed 5–27–09; 8:45 am] 

BILLING CODE 4160–01–S 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30Day–09–08AW] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

The Centers for Disease Control and 

Prevention (CDC) publishes a list of 

information collection requests under 

review by the Office of Management and 

Budget (OMB) in compliance with the 

Paperwork Reduction Act (44 U.S.C. 

Chapter 35). To request a copy of these 

requests, call the CDC Reports Clearance 

Officer at (404) 639–5960 or send an email to omb@cdc.gov. Send written 

comments to CDC Desk Officer, Office of 

Management and Budget, Washington, 

DC or by fax to (202) 395–6974. Written 

comments should be received within 30 

days of this notice. 

Proposed Project 

Quarantine Station Illness Response 

Forms: Airline, Maritime, and Land/ 

Border Crossing—Existing Collection in 

Use without an OMB Number—National 

Center for Preparedness, Detection, and 

Control of Infectious Diseases 

(NCPDCID), Centers for Disease Control 

and Prevention (CDC). 

Background and Brief Description 

CDC proposes to collect patient-level 

clinical, epidemiologic, and 

demographic data from ill travelers and 

their possible contacts in order to fulfill 

its regulatory responsibility to prevent 

the importation of communicable 

diseases from foreign countries (42 CFR 

Part 71) and interstate control of 

communicable diseases in humans (42 

CFR Part 70). 

Section 361 of the Public Health 

Service (PHS) Act (42 U.S.C. 264) 

authorizes the Secretary of Health and 

Human Services to make and enforce 

regulations necessary to prevent the 

introduction, transmission or spread of 

communicable diseases from foreign 

countries into the United States. The 

regulations that implement this law, 42 

CFR Parts 70 and 71, authorize 

quarantine officers and other personnel 

to inspect and undertake necessary 

control measures with respect to 

conveyances (e.g., airplanes, cruise 

ships, trucks, etc.), persons, and 

shipments of animals and etiologic 

agents in order to protect the public 

health. The regulations also require 

conveyances to immediately report an 

‘‘ill person’’ or any death on board to 

the Quarantine Station prior to arrival in 

the United States. An ‘‘ill person’’ is 

defined in statute by: 

— Fever (≥100° F or 38° C) persisting 

≥48 hours. 

— Fever (≥100° F or 38° C) and rash, 

glandular swelling, or jaundice. 

— Diarrhea (≥3 stools in 24 hours or 

greater than normal amount). 

The Severe Acute Respiratory 

Syndrome (SARS) situation and concern 

about pandemic influenza and other 

communicable diseases have prompted 

CDC Quarantine Stations to recommend 

that all illnesses be reported prior to 

arrival. 

CDC Quarantine Stations are currently 

located at 20 international U.S. Ports of 

Entry. When a suspected illness is 

reported to the Quarantine Station, 

officers promptly respond to this report 

by meeting the incoming conveyance 

(when possible), collecting information 

and evaluating the patient(s), and 

determining whether an ill person can 

safely be admitted into the U.S. If 

Quarantine Station staff is unable to 

meet the conveyance, the crew or 

medical staff of the conveyance is 

trained to complete the required 

documentation and forward it (using a 

secure system) to the Quarantine Station 

for review and follow-up. 

To perform these tasks in a 

streamlined manner and ensure that all 

relevant information is collected in the 

most efficient and timely manner 

possible, Quarantine Stations use a 

number of forms—the Airline Screening 

and Illness Response Form, the Ship 

Illness/Death Reporting Form, and the 

Land/Border Crossing Form—to collect 

data on passengers with suspected 

illness and other travelers/crew who 

may have been exposed to an illness. 

These forms are also used to respond to 

a report of a death aboard a conveyance. 

The purpose of all of the forms is the 

same: to collect information that helps 

quarantine officials detect and respond 

to potential public health 

communicable disease threats. All forms 

collect the following categories of 

information: demographics and mode of 

transportation, clinical and medical 

history, and any other relevant facts 

(e.g., travel history, traveling 

companions, etc.). As part of this 

documentation, quarantine public 

health officers look for specific signs 

and symptoms common to the nine 

quarantinable diseases (Pandemic 

influenza; SARS; Cholera; Plague; 

Diphtheria; Infectious Tuberculosis; 

Smallpox; Yellow fever; and Viral 

Hemorrhagic Fevers), as well as most 

communicable diseases in general. 

These signs and symptoms include 

fever, difficulty breathing, shortness of 

breath, cough, diarrhea, jaundice, or 

signs of a neurological infection. The 

forms also collect data specific to the 

traveler’s conveyance. 

These data are used by Quarantine 

Stations to make decisions about a 

passenger’s suspected illness as well as 

its communicability. This in turn 

enables Quarantine Station staff to assist 

conveyances in the public health 

management of passengers and crew. 

The estimated total burden on the 

public, included in the chart below, can 

vary a great deal depending on the 

severity of the illness being reported, 

the number of contacts, the number of 

follow-up inquiries required, and who is 

recording the information (e.g., 

Quarantine Station staff versus the 

conveyance medical authority). In all 

cases, Quarantine Stations have 

implemented practices and procedures 

that balance the health and safety of the 

American public against the public’s 

desire for minimal interference with 

their travel and trade. Whenever 

possible, Quarantine Station staff obtain 

information from other documentation 

(e.g., manifest order, other airline 

documents) to reduce the amount of the 

public burden. 

There is no cost to respondents other 

than their time to complete the survey. 

The estimated annual burden for this 

data collection is 172 hours. 

ESTIMATE OF ANNUALIZED BURDEN

Respondents Form Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Quarantine Staff / Crew or Medical Staff ....... Airline Illness or Death Investigation Form .... 1320 1 6/60 

Federal Register / Vol. 74, No. 101 / Thursday, May 28, 2009 / Notices 25557 

ESTIMATE OF ANNUALIZED BURDEN—Continued 

Respondents Form Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

International Maritime Illness or Death Report.200 1 3/60 

International Maritime Illness or Death Investigation Form.200 1 7/60 

Land Border Illness or Death Investigation 

Form.

60 1 6/60 

Dated: May 19, 2009. 

Maryam I. Daneschvar, 

Acting Reports Clearance Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. E9–12332 Filed 5–27–09; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Indian Health Service 

Office of Urban Indian Health 

Programs; Announcement Type: Title 

V HIV/AIDS Competing Continuation 

Grants 

Funding Opportunity Number: HHS– 

2009–IHS–UIHP–0002. 

Catalog of Federal Domestic 

Assistance Number: 93.193. 

Key Dates 

Application Deadline Date: July 1, 

2009. 

Review Date: July 15, 2009. 

Earliest Anticipated Start Date: 

September 1, 2009. 

I. Funding Opportunity Description 

The Indian Health Service (IHS), 

Office of Urban Indian Health Programs 

(OUIHP) announces an open 

competition for the 4-in-1 Title V grants 

responding to an Office of HIV/AIDS 

Policy (OHAP), Minority AIDS 

(Acquired Immunodeficiency 

Syndrome) Initiative (MAI). This 

program is authorized under the 

authority of the Snyder Act, Public Law 

67–85 and 25 U.S.C. 1652, 1653 of the 

Indian Health Care Improvement Act, 

Public Law 94–437, as amended. This 

program is described at 93.193 in the 

Catalog of Federal Domestic Assistance 

(CFDA). 

This open competition seeks to 

expand OUIHP’s existing Title V grants 

to increase the number of American 

Indian/Alaska Natives (AI/AN) with 

awareness of his/her HIV status. This 

will provide routine and/or rapid HIV 

screening, prevention, pre- and post-test 

counseling (when appropriate). 

Enhancement of urban Indian health 

program HIV/AIDS activities is 

necessary to reduce the incidence of 

HIV/AIDS in the urban Indian health 

communities by increasing access to 

HIV related services, reducing stigma, 

and making testing routine. 

These continuation grants will be 

used to enhance HIV testing, including 

rapid testing and/or standard HIV 

antibody testing and to provide a more 

focused effort to address HIV/AIDS 

prevention, targeting some of the largest 

urban Indian populations in the United 

States. The grantees will attempt to 

provide routine HIV screening for adults 

as per 2006 Centers for Disease Control 

and Prevention (CDC) guidelines, preand post-test counseling (when 

appropriate). These grants will be used 

to identify best practices to enhance HIV 

testing, including rapid testing and/or 

conventional HIV antibody testing, and 

to provide a more focused effort to 

address HIV/AIDS prevention in AI/AN 

populations in the United States. 

The nature of these projects will 

require collaboration with the OUIHP 

to: (1) Coordinate activities with the IHS 

National HIV Program; (2) participate in 

projects in other operating divisions of 

the Department of Health and Human 

Services (HHS) such as the CDC, 

Substance Abuse and Mental Health 

Services Administration, Health 

Resource and Services Administration 

and the Office of HIV/AIDS Policy; and 

(3) submit and share anonymous, nonidentifiable data on HIV/AIDS testing, 

treatment, and education. 

These grants are also intended to 

encourage development of sustainable, 

routine HIV screening programs in 

urban facilities that are aligned with 

2006 CDC HIV Screening guidelines 

(http://www.cdc.gov/mmwr/preview/ 

mmwrhtml/rr5514a1.htm). Key features 

include streamlined consent and 

counseling procedures (verbal consent, 

opt-out), a clear HIV screening policy, 

identifying and implementing any 

necessary staff training, community 

awareness, and a clear followup 

protocol for HIV positive results 

including linkages to care. Grantees may 

choose to bundle HIV tests with STD 

screening. 

II. Award Information 

Type of Award: Title V Continuation 

Grants. 

Estimated Funds Available: The total 

amount identified for Fiscal Year (FY) 

2009 is ten awards totaling $200,000. 

Individual awards must include one 

project evaluation and provide 

administrative support of the project. 

All future awards under this 

announcement are subject to the 

availability of funds. Hence, the agency 

has no obligation to award additional 

funding beyond the first year. 

Anticipated Number of Awards: Ten 

grant awards will be made under the 

program. 

Project Period: September 1, 2009– 

August 31, 2012. 

Award Amount: $200,000. 

A. Requirements of Recipient Activities 

In FY 2009, each grantee’s attempted 

goal shall include screening as many 

individuals as possible; however, each 

funded program’s attempted goal will be 

to increase screening to a minimum of 

300 AI/AN tested per program funded 

(adjusted due to variations in size of 

facility and user population), for a total 

of 4,500 AI/AN tested. This reflects an 

MAI requirement to maintain the actual 

cost per MAI Fund HIV testing client 

below the medical care inflation rate. 

This does not include counts of retesting individuals in the same year. 

Each program shall also collect 

evidence, as part of the testing process, 

to document lessons learned, best 

practices, and barriers to increased 

routine HIV screening within this 

population. 

III. Eligibility Information 

1. Eligible Applicants: Urban Indian 

organizations, as defined by 25 U.S.C. 

1603(h), limited to urban Indian 

organizations which meet the following 

criteria: 

• Received State certification to 

conduct HIV rapid testing (where 

needed);